Amryt Pharma plc AMYT
14.70 +14.70
Day range unavailable
52-week range unavailable
News
proactiveinvestors.com Poolbeg Pharma beefs up leadership; brings key players from succesful Amryt Pharma team In a strategic move to strengthen its management team, Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) has announced the appointment of key former executives from Amryt Pharma, underscoring its commitment…
seekingalpha.com Amryt Pharma: Final Chance To Pick Up An Attractive CVR Amryt Pharma is being acquired at $14.50 per share and a contingent value right and is trading at $14.69. The contingent value right consists of 2 milestones that pay out $1 and $1.50 on certain…
fool.com Why Shares of Amryt Pharma Jumped This Week A takeover bid by an Italian pharmaceutical and healthcare company boosted Amryt's shares.
seekingalpha.com Acquisition Of Amryt Pharma: How To Profit From Orphan Drugs Developers Amryt Pharma plc will be acquired by Chiesi Farmaceutici S.p.A. Amryt Pharma is valued at $1.25 billion plus $225 million upon achievement of certain pipeline development milestones.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For January 10, 2023 
benzinga.com Why Cutera Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Monday's Mid-Day Session Gainers CinCor Pharma, Inc. (NASDAQ: CINC) shares jumped 137% to $27.93 after AstraZeneca announced it will acquire the company for $26 per share in cash.
zacks.com New Strong Sell Stocks for December 7th ABST, AMYT and ARCE have been added to the Zacks Rank #5 (Strong Sell) List on December 7, 2022.
zacks.com New Strong Sell Stocks for November 17th BRFS, AOS and AMYT have been added to the Zacks Rank #5 (Strong Sell) List on November 17, 2022.
zacks.com New Strong Sell Stocks for November 16th EGO, BRFS and AMYT have been added to the Zacks Rank #5 (Strong Sell) List on November 16, 2022.
zacks.com New Strong Sell Stocks for November 10th AMYT, CHRD and BKI have been added to the Zacks Rank #5 (Strong Sell) List on November 10, 2022.
seekingalpha.com Amryt Pharma PLC (AMYT) Q3 2022 Earnings Call Transcript Amryt Pharma PLC (NASDAQ:AMYT ) Q3 2022 Earnings Conference Call November 3, 2022 8:30 AM ET Company Participants Simon Loughrey - Group Financial Controller Joseph Wiley - CEO & Director Rory Nealon…
benzinga.com Earnings Scheduled For November 3, 2022 Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.
globenewswire.com Amryt to Report Q3 2022 Results on November 3, 2022 A mryt to Report Q 3 202 2 Results on November 3 , 2022
globenewswire.com Amryt to Present Data from MPOWERED Phase 3 Trial of Mycapssa® (oral octreotide) at ENEA 2022 Amryt to Present Data from MPOWERED Phase 3 Trial of Mycapssa® (oral octreotide) at ENEA 2022
seekingalpha.com Amryt Pharma plc (AMYT) CEO Joseph Wiley on Q2 2022 Results - Earnings Call Transcript Amryt Pharma plc (NASDAQ:AMYT ) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Simon Loughrey - Group Financial Controller Joseph Wiley - Chief Executive Officer Rory…
zacks.com Amryt Pharma PLC Sponsored ADR (AMYT) Reports Q2 Loss, Tops Revenue Estimates Amryt Pharma PLC Sponsored ADR (AMYT) delivered earnings and revenue surprises of 50% and 9.55%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the…
benzinga.com Earnings Scheduled For August 4, 2022 Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for its first quarter.
globenewswire.com Amryt to Report Q2 2022 Results on August 4, 2022 DUBLIN, Ireland, and Boston MA, July 21 , 202 2 , Amryt (Nasdaq: AMYT) a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for…
zacks.com Amryt (AMYT) Mycapssa Gets Orphan Drug Tag for Carcinoid Syndrome The FDA bestows an Orphan Drug designation to Amryt's (AMYT) Mycapssa for the treatment of carcinoid syndrome. Stock up in pre-market trading.
zacks.com Amryt Pharma PLC Sponsored ADR (AMYT) Surges 7.5%: Is This an Indication of Further Gains? Amryt Pharma PLC Sponsored ADR (AMYT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into…
globenewswire.com Amryt to Present Data from OPTIMAL and MPOWERED Phase 3 Trials Open Label Extension of Mycapssa® (oral octreotide) at ENDO 2022 Amryt to Present Data from OPTIMAL and MPOWERED Phase 3 Trials Open Label Extension of Mycapssa® (oral octreotide) at ENDO 2022
seekingalpha.com Amryt Pharma PLC (AMYT) CEO Joseph Wiley on Q1 2022 Results - Earnings Call Transcript Amryt Pharma PLC (NASDAQ:AMYT ) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Simon Loughrey - Group Financial Controller Joseph Wiley - CEO & Director Rory Nealon -…
zacks.com Amryt Pharma PLC Sponsored ADR (AMYT) Reports Q1 Loss, Tops Revenue Estimates Amryt Pharma PLC Sponsored ADR (AMYT) delivered earnings and revenue surprises of 0% and 2.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the…
benzinga.com Earnings Scheduled For May 4, 2022 Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
benzinga.com Amryt Shares Trading Higher As EMA Endorses Approval Of Filsuvez In Genetic Skin Disease The European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has backed the approval of Amryt Pharma Plc's (NASDAQ: AMYT) Filsuvez in the European Union for partial thickness…
benzinga.com Earnings Scheduled For March 9, 2022 Companies Reporting Before The Bell • REV Group (NYSE:REVG) is expected to report quarterly earnings at $0.11 per share on revenue of $529.44 million.- benzinga.com The Week Ahead In Biotech (March 6-12): Quiet Week On Tap With Earnings Season Reaching It Final Leg Biotech stocks reversed course in the week ending March 4, as the Ukrainian crisis weighed down on the broader market as well as the sector. The iShares Biotechnology ETF (NASDAQ: IBB) retreated in…
- benzinga.com 67 Biggest Movers From Yesterday Gainers
benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday morning, 66 companies achieved new lows for the year.
benzinga.com The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight Biopharma stocks lock-stepped with the broader market in the week ending Feb. 25 before finishing higher. The trajectory was the same, with the sector declining in the first two sessions of the…- benzinga.com Stocks That Hit 52-Week Lows On Wednesday On Wednesday, 348 companies hit new 52-week lows.
benzinga.com Stocks That Hit 52-Week Lows On Tuesday During Tuesday's trading, 505 companies set new 52-week lows.- benzinga.com Stocks That Hit 52-Week Lows On Thursday On Thursday, 147 companies achieved new lows for the year.
- benzinga.com Earnings Scheduled For November 3, 2021 Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2021
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2021
- benzinga.com Earnings Scheduled For March 4, 2021 Companies Reporting Before The Bell • Toro (NYSE:TTC) is expected to report quarterly earnings at $0.75 per share on revenue of $851.38 million.
- benzinga.com Earnings Scheduled For November 5, 2020 Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stock (AMEX:BRG) is expected to report quarterly loss at $0.64 per share on revenue of $52.59 million.
- benzinga.com Stocks That Hit 52-Week Highs On Tuesday During Tuesday's morning session, 138 companies made new 52-week highs.